These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1444295)

  • 1. Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
    Morgan ME; Chi SC; Murakami K; Mitsuya H; Anderson BD
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2156-65. PubMed ID: 1444295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats.
    Savolainen J; Edwards JE; Morgan ME; McNamara PJ; Anderson BD
    Drug Metab Dispos; 2002 May; 30(5):479-82. PubMed ID: 11950774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
    Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H
    J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Ford H; Siddiqui MA; Driscoll JS; Marquez VE; Kelley JA; Mitsuya H; Shirasaka T
    J Med Chem; 1995 Mar; 38(7):1189-95. PubMed ID: 7707321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
    Singhal D; Anderson BD
    J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys.
    Hawkins ME; Mitsuya H; McCully CM; Godwin KS; Murakami K; Poplack DG; Balis FM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1259-64. PubMed ID: 7574512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.
    Shanmuganathan K; Koudriakova T; Nampalli S; Du J; Gallo JM; Schinazi RF; Chu CK
    J Med Chem; 1994 Mar; 37(6):821-7. PubMed ID: 8145233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.
    Shirasaka T; Murakami K; Ford H; Kelley JA; Yoshioka H; Kojima E; Aoki S; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9426-30. PubMed ID: 2251284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cultured cerebral capillary endothelial cells in modeling the central nervous system availability of 2',3'-dideoxyinosine.
    Johnson MD; Anderson BD
    J Pharm Sci; 2000 Mar; 89(3):322-35. PubMed ID: 10707013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD; Chen J; Anderson BD
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological behaviour of 6-chloro-2',3'-dideoxyguanosine and 6-chloro-2',3'-dideoxyinosine in the brains of mice.
    Fujii Y; Kojima E; Ohtani I; Mukai R; Murakami K; Yoshikawa Y
    Nucleic Acids Symp Ser; 1997; (37):173-4. PubMed ID: 9586055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
    Hoesterey BL; Galinsky RE; Anderson BD
    Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of lipophilic 6-halo-2',3'-dideoxypurine nucleoside and derivatives: approach to develop CNS-targeting anti-HIV agents].
    Murakami K; Kojima E; Kojima E; Shirasaka T; Mitsuya H
    Nihon Rinsho; 1993 Sep; 51 Suppl():132-8. PubMed ID: 8271376
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms by which 2',3'-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy.
    Gibbs JE; Jayabalan P; Thomas SA
    J Neurochem; 2003 Feb; 84(4):725-34. PubMed ID: 12562517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Driscoll JS; Siddiqui MA; Ford H; Kelley JA; Roth JS; Mitsuya H; Tanaka M; Marquez VE
    J Med Chem; 1996 Apr; 39(8):1619-25. PubMed ID: 8648601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.